These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 31902581)

  • 41. Effect of time and duration of untreated psychosis on cognitive and social functioning in Chinese patients with first-episode schizophrenia: A 1-year study.
    Heeramun-Aubeeluck A; Liu N; Fischer F; Huang N; Chen F; He L; Yang C; Luo Y; Lu Z
    Nord J Psychiatry; 2015 May; 69(4):254-61. PubMed ID: 25731069
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Early interventions in a US military FIRST episode psychosis program.
    Hann MC; Caporaso E; Loeffler G; Cuellar A; Herrington L; Marrone L; Yoon J
    Early Interv Psychiatry; 2018 Dec; 12(6):1243-1249. PubMed ID: 29971958
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hippocampal Dysconnectivity and Altered Glutamatergic Modulation of the Default Mode Network: A Combined Resting-State Connectivity and Magnetic Resonance Spectroscopy Study in Schizophrenia.
    Nelson EA; Kraguljac NV; Maximo JO; Briend F; Armstrong W; Ver Hoef LW; Johnson V; Lahti AC
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2022 Jan; 7(1):108-118. PubMed ID: 32684484
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Which pathways to psychiatric care lead to earlier treatment and a shorter duration of first-episode psychosis?
    Bhui K; Ullrich S; Coid JW
    BMC Psychiatry; 2014 Mar; 14():72. PubMed ID: 24620939
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dorsal striatial hypoconnectivity predicts antipsychotic medication treatment response in first-episode psychosis and unmedicated patients with schizophrenia.
    Nelson EA; Kraguljac NV; Maximo JO; Armstrong W; Lahti AC
    Brain Behav; 2022 Nov; 12(11):e2625. PubMed ID: 36237115
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Symptom Remission and Brain Cortical Networks at First Clinical Presentation of Psychosis: The OPTiMiSE Study.
    Dazzan P; Lawrence AJ; Reinders AATS; Egerton A; van Haren NEM; Merritt K; Barker GJ; Perez-Iglesias R; Sendt KV; Demjaha A; Nam KW; Sommer IE; Pantelis C; Wolfgang Fleischhacker W; van Rossum IW; Galderisi S; Mucci A; Drake R; Lewis S; Weiser M; Martinez Diaz-Caneja CM; Janssen J; Diaz-Marsa M; Rodríguez-Jimenez R; Arango C; Baandrup L; Broberg B; Rostrup E; Ebdrup BH; Glenthøj B; Kahn RS; McGuire P;
    Schizophr Bull; 2021 Mar; 47(2):444-455. PubMed ID: 33057670
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Influence of duration of untreated psychosis on auditory P300 in drug-naive and first-episode schizophrenia.
    Wang J; Hirayasu Y; Hokama H; Tanaka S; Kondo T; Zhang M; Xiao Z
    Psychiatry Clin Neurosci; 2005 Apr; 59(2):209-14. PubMed ID: 15823170
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Distinct intrinsic functional brain network abnormalities in methamphetamine-dependent patients with and without a history of psychosis.
    Ipser JC; Uhlmann A; Taylor P; Harvey BH; Wilson D; Stein DJ
    Addict Biol; 2018 Jan; 23(1):347-358. PubMed ID: 27917569
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Differential impacts of duration of untreated psychosis (DUP) on cognitive function in first-episode schizophrenia according to mode of onset.
    Ito S; Nemoto T; Tsujino N; Ohmuro N; Matsumoto K; Matsuoka H; Tanaka K; Nishiyama S; Suzuki M; Kinoshita H; Ozawa H; Fujita H; Shimodera S; Kishimoto T; Matsumoto K; Hasegawa T; Mizuno M
    Eur Psychiatry; 2015 Nov; 30(8):995-1001. PubMed ID: 26497470
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Neurometabolic and functional changes of default-mode network relate to clinical recovery in first-episode psychosis patients: A longitudinal
    Li W; Xu J; Xiang Q; Zhuo K; Zhang Y; Liu D; Li Y
    Neuroimage Clin; 2022; 34():102970. PubMed ID: 35240468
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Duration of untreated psychosis and acute remission of negative symptoms in a South American first-episode psychosis cohort.
    González-Valderrama A; Castañeda CP; Mena C; Undurraga J; Mondaca P; Yañez M; Bedregal P; Nachar R
    Early Interv Psychiatry; 2017 Feb; 11(1):77-82. PubMed ID: 26256570
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Advancing study of cognitive impairments for antipsychotic-naïve psychosis comparing high-income versus low- and middle-income countries with a focus on urban China: Systematic review of cognition and study methodology.
    Yang LH; Ruiz B; Mandavia AD; Grivel MM; Wong LY; Phillips MR; Keshavan MS; Li H; Lieberman JA; Susser E; Seidman LJ; Stone WS
    Schizophr Res; 2020 Jun; 220():1-15. PubMed ID: 32269004
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Duration of untreated psychosis: a proposition regarding treatment definition.
    Polari A; Lavoie S; Sarrasin P; Pellanda V; Cotton S; Conus P
    Early Interv Psychiatry; 2011 Nov; 5(4):301-8. PubMed ID: 22032548
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Duration of untreated psychosis and response to treatment: an analysis of response in the OPTiMiSE cohort.
    Levi L; Bar Haim M; Burshtein S; Winter-Van Rossum I; Heres S; Davidson M; Shenkman G; Kahn RS; Weiser M
    Eur Neuropsychopharmacol; 2020 Mar; 32():131-135. PubMed ID: 32037127
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Glutamate levels in the associative striatum before and after 4 weeks of antipsychotic treatment in first-episode psychosis: a longitudinal proton magnetic resonance spectroscopy study.
    de la Fuente-Sandoval C; León-Ortiz P; Azcárraga M; Stephano S; Favila R; Díaz-Galvis L; Alvarado-Alanis P; Ramírez-Bermúdez J; Graff-Guerrero A
    JAMA Psychiatry; 2013 Oct; 70(10):1057-66. PubMed ID: 23966023
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Short-term Medication Effects on Brain Functional Activity and Network Architecture in First-Episode psychosis: a longitudinal fMRI study.
    Zhang Y; Xiang Q; Huang CC; Zhao J; Liu Y; Lin CP; Liu D; Lo CZ
    Brain Imaging Behav; 2023 Apr; 17(2):137-148. PubMed ID: 36646973
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Who needs antipsychotic medication in the earliest stages of psychosis? A reconsideration of benefits, risks, neurobiology and ethics in the era of early intervention.
    Francey SM; Nelson B; Thompson A; Parker AG; Kerr M; Macneil C; Fraser R; Hughes F; Crisp K; Harrigan S; Wood SJ; Berk M; McGorry PD
    Schizophr Res; 2010 Jun; 119(1-3):1-10. PubMed ID: 20347270
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Duration of active psychosis and first-episode psychosis negative symptoms.
    Lyne J; Joober R; Schmitz N; Lepage M; Malla A
    Early Interv Psychiatry; 2017 Feb; 11(1):63-71. PubMed ID: 25582878
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Duration of Untreated Disorder and Cannabis Use: An Observational Study on a Cohort of Young Italian Patients Experiencing Psychotic Experiences and Dissociative Symptoms.
    Ricci V; Martinotti G; Ceci F; Chiappini S; Di Carlo F; Burkauskas J; Susini O; Luciani D; Quattrone D; De Berardis D; Pettorruso M; Maina G; Di Giannantonio M
    Int J Environ Res Public Health; 2021 Nov; 18(23):. PubMed ID: 34886357
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Neurometabolic correlates of 6 and 16 weeks of treatment with risperidone in medication-naive first-episode psychosis patients.
    Birur B; Kraguljac NV; VerHoef L; Morgan CJ; Jindal RD; Reid MA; Luker A; Lahti AC
    Transl Psychiatry; 2020 Jan; 10(1):15. PubMed ID: 32066680
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.